← 글 목록← All articles

Supreme Court en banc Decision 2011Hu927 Decided January 22, 2015: how are product-by-process claims construed in Korea?

Brief summary

  • The Supreme Court of Korea treated a product-by-process claim as an invention of a product. The manufacturing process recited in the claim is one means of specifying the structure or properties, etc. of the final product. [1]
  • The requirements for patentability are assessed on the product. The product that has the structure or properties, etc. specified by all recitations of the claims, including the recited manufacturing process, is compared with the prior art. [1]
  • The Supreme Court did not divide the interpretation according to whether there are circumstances in which the product can only be specified by its manufacturing process. The earlier decisions that divided the interpretation by those circumstances were overruled by this decision. [1]

Last verified

The case

Item Content
Court Supreme Court of Korea
Date of decision 22 January 2015
Case number 2011Hu927 (2011후927)
Case name Invalidation of Registration (Patent) (등록무효(특))
Lower court Patent Court Decision 2008Heo6239 Decided April 8, 2011
Outcome The part of the lower judgment concerning claims 9 and 10 was reversed, and the case was remanded to the Intellectual Property High Court of Korea (Patent Court of Korea). The remainder of the final appeal was dismissed
En banc or not It is an en banc decision. It was decided by the assent of all participating Justices
Reference Provisions (written judgment) Patent Act (특허법), Art. 2, subparagraph 3

The content of this table is taken from the written judgment. [1] The written judgment bears 13 names, including that of the Presiding Justice. [1]

The written judgment calls this claim “제조방법이 기재된 물건발명” (an invention of a product in which a manufacturing process is recited). [1] The Patent Examination Guidelines (특허·실용신안 심사기준) call the same thing “제법한정 물건발명” (a product-by-process invention). [9] This article follows the wording of the written judgment and calls the claim a “product-by-process claim”.

The issue: if the manufacturing process involves an inventive step, does the product made by that process also involve an inventive step?

This case is an invalidation case for a patent. The disputed claims fall into two groups. Claims 6 and 7 are claims to a process for manufacturing a film. Claims 9 and 10 claim a product manufactured by the process of claim 6. [1]

The lower court, the IP High Court of Korea, held that the inventive step of claims 6 and 7 was not denied. The lower court then held that the inventive step of claims 9 and 10 was not denied either. It drew this conclusion directly from its finding that the inventive step of claim 6 was not denied. [1]

The defendant filed a final appeal. The issue is how claims 9 and 10 are to be read. The question is whether the requirements for patentability of a product-by-process claim are assessed on the manufacturing process or on the product. [1]

The earlier decisions divided the cases. The test was whether there were special circumstances, such as the product being specifiable only by its manufacturing process. Without such circumstances, the earlier decisions said that the manufacturing process itself need not be considered. Their point was that only the invention specified as a product by the recitations of the claims had to be compared with the prior art. [1] [6]

What the court held 1: it is an invention of a product even where a manufacturing process is recited

The Supreme Court started from Article 2, subparagraph 3 of the Patent Act. This provision divides inventions into inventions of a product, inventions of a process and inventions of a process for manufacturing a product. [1]

The Supreme Court defined the invention of a product-by-process claim as follows. It is an invention whose claims are written as a product as a whole and include the recitation of its manufacturing process. The subject of this invention is not the manufacturing process but the product that is finally obtained. This invention therefore falls under the invention of a product among the three categories. [1]

The Supreme Court also set out the meaning of the manufacturing process recited in the claim. The claims of an invention of a product must be written in a way that specifies the configuration of the product. The manufacturing process recited in them only has meaning as one means of specifying the “structure or properties, etc.” of the product that is the final product. [1]

The method of assessing the requirements for patentability follows from this. The technical configuration of the invention is not understood as limited to the manufacturing process itself. It is understood as a product that has the structure or properties, etc. specified by all recitations of the claims, including the recited manufacturing process. That product is compared with the prior art publicly known before the filing, to examine whether there is novelty, an inventive step, etc. [1]

What the court held 2: the interpretation is the same even where there are special circumstances

The Supreme Court accepted that there can be circumstances in which a product can only be specified by its manufacturing process. It gave as examples the field of biotechnology and the chemical fields of polymers, mixtures, metals, etc. The Supreme Court said that, among the products in these fields, there can be products that are impossible or difficult to specify directly by their structure or properties, etc. [1]

The Supreme Court said that an invention with those circumstances is also, in its nature, an invention of a product. It said that the manufacturing process recited in the claims is likewise a means of specifying the structure or properties, etc. of the product. It therefore said that the meaning of the manufacturing process is not to be interpreted differently by distinguishing inventions with those circumstances from inventions without them. [1]

What the court held 3: the inventive step of a process claim is not the inventive step of a product claim

The Supreme Court applied this standard to the case. Claims 9 and 10 are product-by-process claims. The lower court should have compared with the prior art only the invention of a product that has the structure or properties specified by all recitations, including the recited manufacturing process. [1]

The lower court did not do so. It held that the inventive step of the product claims was not denied, for the sole reason that the inventive step of the invention of the manufacturing process was not denied. The Supreme Court found that this holding was unlawful for misapprehending the legal principle. [1]

The final appeal concerning claims 6 and 7 was dismissed. The Supreme Court said that the lower court was right to hold that the inventive step of the two claims was not denied. [1]

How a product-by-process claim is construed in Korea

What the court did not decide

The Supreme Court did not decide whether claims 9 and 10 involve an inventive step. This part was remanded to the IP High Court of Korea to be heard and decided again. [1]

What this decision stated is the interpretation used when the requirements for patentability are assessed. How the scope of the right is determined in patent infringement litigation or in a trial to confirm the scope of a right does not appear in this decision. That question was addressed three weeks later in Supreme Court Decision 2013Hu1726. [1] [2]

The decision wrote the requirements to be compared with the prior art as “novelty, an inventive step, etc.” What was actually decided in this case is the inventive step. [1]

The decision did not address the description requirements for the claims. Whether a product-by-process claim is clear is a question under Article 42(4), subparagraph 2 of the Patent Act. The only Reference Provision in the written judgment is Article 2, subparagraph 3. [1] [7]

Who shows, and how, whether the manufacturing process affects the structure or properties of the product also does not appear in the decision. [1]

Before and after this decision: the decisions it overruled and the decisions that followed

The decisions that this decision overruled

The Supreme Court overruled seven earlier decisions, naming their case numbers. [1]

  • Supreme Court Decision 2004Hu3416 Decided June 29, 2006
  • Supreme Court Decision 2007Hu449 Decided May 11, 2007
  • Supreme Court Decision 2006Hu1100 Decided September 20, 2007
  • Supreme Court Decision 2006Hu3472 Decided August 21, 2008
  • Supreme Court Decision 2007Hu1053 Decided January 15, 2009
  • Supreme Court Decision 2006Hu3250 Decided March 26, 2009
  • Supreme Court Decision 2007Hu4328 Decided September 24, 2009

The Supreme Court also overruled other decisions to the same effect. They are overruled to the extent that they are inconsistent with the opinion of this decision. [1]

Of the seven, the written judgment of the 2006 decision was read for this article. That decision said that, unless there are special circumstances, the manufacturing process itself need not be considered. It said that only the invention specified as a product by the recitations of the claims has to be compared with the inventions, etc. publicly known before the filing. [6]

The same interpretation applies at the infringement stage

Supreme Court Decision 2013Hu1726 Decided February 12, 2015 is a case on confirmation of the scope of rights. This decision cited the method of interpretation of Supreme Court en banc Decision 2011Hu927 as it stands. It then said that the method of interpretation must apply in the same way at the stage of patent infringement. That is, when it is determined in patent infringement litigation, a trial to confirm the scope of a right, etc. whether something falls within the scope of the right. [2]

Supreme Court Decision 2013Hu1726 made one exception. It is the case where there are “clearly unreasonable circumstances” in the scope of the right derived by this method of interpretation. The example given by the decision is the case where the scope of the right is too broad in light of the substance of the invention as understood from the specification as a whole. In that case, the scope of the right may be limited to the scope of the manufacturing process recited in the claims. [2]

The claim in that case was a pharmaceutical composition whose active ingredient is a compound manufactured by a specific extraction and purification process. The Supreme Court found that the manufacturing process does not affect the structure or properties of the compound. It therefore construed the active ingredient as the single product itself, namely that compound. The Supreme Court said that there were no clearly unreasonable circumstances in this construction. The Supreme Court gave two points. One is that the manufacturing process is separately claimed in another claim. The other is that the specification describes embodiments in which experiments were carried out with the compound itself. [2]

The lower court had construed the scope of the right as limited to the manufacturing process. The Supreme Court said that this construction was wrong. However, it found that the lower court’s conclusion that the accused invention does not fall within the scope of the right was correct, and dismissed the final appeal. The reason is that the active ingredient of the accused invention is neither identical nor equivalent to the active ingredient of the claim. The Supreme Court said that the accused invention also cannot be regarded as using the invention of the claim as it is. [2]

The decisions that followed

Supreme Court Decision 2020Hu11059 Decided January 28, 2021 cited Supreme Court en banc Decision 2011Hu927 in a case on confirmation of the scope of rights. It said that, when it is determined whether something falls within the scope of the right, the invention is likewise understood as a product that has the structure or properties, etc. specified by all recitations. It said that this product must be compared with the accused invention. [3]

In that case, the manufacturing processes of the claim and of the accused invention were different. The patented invention was a tablet with the structure and properties specified by being manufactured by a direct compression method. The accused invention was a tablet with the structure and properties, etc. specified by being manufactured by a wet method. On the basis of this difference, the lower court held that the accused invention does not literally fall within the scope of the right. It did not recognize equivalence either. The Supreme Court upheld the holding of the lower court and dismissed the final appeal. [3]

Supreme Court Decision 2020Hu11066, decided on the same day, applied the same legal principle. The accused invention in that case was a tablet manufactured by a wet granulation method, and the conclusion was the same. [4]

Supreme Court Decision 2019Hu10296 Decided December 30, 2021 is an invalidation case. In assessing the inventive step, this decision cited the standard of Supreme Court en banc Decision 2011Hu927 as it stands. The disputed claim was a claim to a product obtained by the manufacturing process of a process claim. This claim limited the structure and properties of the product by physical properties such as molecular weight, solubility and particle size. The Supreme Court compared those physical properties with the prior art and then found that the inventive step was not denied. [5]

A case search of the Ministry of Government Legislation (법제처) returned no decision that overrules Supreme Court en banc Decision 2011Hu927 (searched on 9 October 2026).

How did the Patent Examination Guidelines take up this decision?

The Guidelines were amended in the year in which the decision was rendered. In the amendment history of the Guidelines, the amendment of April 2015 is recorded as an “amendment of the examination guidelines on product-by-process inventions, etc.” The preface of the Guidelines records an amendment of 2 April 2015 (KIPO Established Rule No. 82). The Addenda dated 6 April 2015 that are printed in the Guidelines set the enforcement date at 6 April 2015. These Addenda contain only an enforcement date and a review deadline, and no applicability provision. [9]

The current Guidelines (MOIP Established Rule No. 7, in force from 13 March 2026) cite this decision in two places, on novelty and on the inventive step. They are Part 3, Chapter 2, 4.1.2 (3) and Part 3, Chapter 3, 6.4.4. The Addenda of the current Established Rule contain only an enforcement date and a review deadline, and no applicability provision. [9]

The Guidelines divide the cases by whether the manufacturing process affects the structure or properties, etc. of the product. [9]

Case What is assessed for novelty and the inventive step
The manufacturing process affects the structure or properties, etc. of the product The product that has the structure or properties, etc. specified by the manufacturing process
The manufacturing process does not affect the structure or properties, etc. of the product, for example because it affects only manufacturing efficiency or yield The finally obtained product itself, leaving out the manufacturing process

The Guidelines state that what is assessed for the inventive step is the product. The examiner does not assess whether the manufacturing process or the manufacturing apparatus is patentable. The examiner compares the configuration of the product that has the structure or properties, etc. specified by being manufactured by that process with the configuration of a publicly known product. [9]

The inventive step part of the Guidelines (6.4.4) has further cases in which a notice of grounds for rejection may be issued. One is the case where it is difficult to understand the structure or properties, etc. of the product from the manufacturing process of the claim. In this case, the examiner understands the scope of the invention by referring to the specification as a whole, such as its experimental data, embodiments and drawings. There is also the case where the prior art discloses a manufacturing process identical or similar to the manufacturing process of the claim. The Guidelines state that, in this case, an identical or similar product is presumed to be produced. There is also the case where it is difficult to determine whether the manufacturing process has affected the structure or properties, etc. In this case, the examiner looks at a cited invention that is similar to the product itself without considering the manufacturing process. If there is a reasonable doubt that the inventive step is denied by that cited invention, the examiner may issue a notice of grounds for rejection. [9]

Clarity is examined separately. Part 2, Chapter 4, 4.(8) of the Guidelines states that a product claim may be written by using a manufacturing process. However, if the manufacturing process recited in the claim is unclear, a notice of grounds for rejection may be issued for violation of Article 42(4), subparagraph 2 of the Patent Act. The same applies where the claim is so unclear that the structure or characteristics, etc. of the product cannot be understood. [9]

The Guidelines give two cases in which the latter ground for rejection is resolved. One is where the applicant has proved special circumstances, such as the product being specifiable only by that manufacturing process. The other is where the applicant has proved that the manufacturing process has no effect at all on the structure or properties of the product. The Guidelines state that, in these cases, the ground for rejection is regarded as resolved and no decision of rejection (decision to reject a patent application) is issued. [9]

This part of the Guidelines concerns the ground for rejection for lack of clarity. What Supreme Court en banc Decision 2011Hu927 said it would not distinguish is the interpretation of the meaning of the manufacturing process. [1] [9]

Have the provisions interpreted by the decision changed since then?

The written judgment uses the word “특허청구범위” (literally, “patent claims”). [1] This is the word of the Patent Act before amendment. Act No. 12753 changed “특허청구범위” in Articles 42 and 97 to “청구범위” (“claims”). Act No. 12753 was promulgated on 11 June 2014. The amended provisions of Articles 42 and 97 entered into force on 1 January 2015 (Addenda, Art. 1, main clause). [7] [8]

Article 8 of the Addenda to Act No. 12753 is a general transitional measure. It provides that patent applications filed before this Act enters into force, and the examination and trials for those patent applications, are governed by the previous provisions. [8] The written judgment does not state the Act number of the Patent Act that it applied. [1] The three decisions of 2021 wrote the same standard with the word “청구범위”. [3] [4] [5]

Act No. 12753 also wholly amended Article 2. The three categories in subparagraph 3 and the acts of working (practice) set by each item are the same as before the amendment, and only the wording of the sentences changed. [8]

Article 2, subparagraph 3 was amended twice after that. [7] [8]

  • Act No. 16804 added “offering the use of the process” to item (b). Item (b) sets the working of an invention of a process. This Act was promulgated on 10 December 2019 and entered into force on 11 March 2020.
  • Act No. 20700 added “exporting” to items (a) and (c). Item (a) sets the working of an invention of a product, and item (c) sets the working of an invention of a process for manufacturing a product. This Act was promulgated on 21 January 2025 and entered into force on 22 July 2025.

The Addenda to the two Acts contain no applicability provision or transitional measure concerning Article 2. [8] The framework that divides inventions into three categories is the same in the provision before amendment by Act No. 12753 and in the current provision. [7] [8]

The decision classified the invention of a product-by-process claim as an invention of a product. [1] The current Article 2, subparagraph 3 (a) sets the working of an invention of a product as follows. It is manufacturing, using, assigning, leasing, exporting or importing the product, and offering to assign or lease the product. Offering includes displaying the product for the purpose of assigning or leasing. [7]

The current Article 97 provides that the scope of protection of a patented invention is determined by the matters stated in the claims. The current Article 42(6) provides that the claims must state the matters deemed necessary to specify the invention. What the provision lists is structures, methods, functions, materials, or combinations thereof, etc. [7] A patent that violates Article 29 is subject to a trial for invalidation (Art. 133(1), subparagraph 1). [7]

The amended Patent Act (Act No. 21955) was promulgated on 15 September 2026 and enters into force on 16 March 2027. Articles 2, 29, 42, 97 and 133 are the same in the version scheduled to enter into force as they are now. [7]

Claim formats in general are covered in “Which claim formats does Korea accept?“. The inventive step standard is covered in “What is the inventive step standard under Article 29(2) of the Korean Patent Act?“. The trial to confirm the scope of a right is covered in “What is a trial to confirm the scope of a right in Korea?”.

What changes in practice

The following is the opinion of DEFINE IP Law Firm. The response in an individual case depends on the facts, so please confirm it with your agent.

  • At the filing stage, it is difficult to defend a product claim only by arguing that the manufacturing process is new. We suggest stating in the specification how the structure or properties of the product differ because of that manufacturing process. Experimental data and embodiments serve as that material.
  • If the manufacturing process itself is the core of the invention, in general we suggest including a separate claim to the manufacturing process. In this decision too, the conclusions for the process claims and the product claims diverged.
  • When claims of a foreign application are adapted for Korea, we suggest reviewing product-by-process claims separately. What is compared with the prior art differs according to whether the manufacturing process affects the structure or properties of the product.
  • The party filing a petition for a trial for invalidation can search for prior art directed at the product, not at the process. Even a product made by a different process is something to compare with, if its structure or properties are the same.
  • At the infringement stage, we suggest that both sides first set out the effect of the manufacturing process on the structure or properties of the product. The claim constructions in Supreme Court Decision 2013Hu1726 of 2015 and Supreme Court Decision 2020Hu11059 of 2021 diverged on this point. Both decisions concluded that the accused invention does not fall within the scope of the right.

FAQ

Can a product-by-process claim be used in Korea?

Yes. The Guidelines state that a claim to a product may be written by using a manufacturing process. However, the claim is examined for clarity under Article 42(4), subparagraph 2 of the Patent Act. [9]

If the manufacturing process is new, is the claim to the product made by that process also registered?

That alone does not decide it. The requirements for patentability are assessed on the product that has the structure or properties, etc. specified by all recitations, including the recited manufacturing process. [1]

Is the interpretation different for a product that can only be specified by its manufacturing process?

No. The Supreme Court said that the meaning of the manufacturing process is not to be interpreted differently by distinguishing inventions with those circumstances from inventions without them. [1]

Does the same product made by a different process fall within the scope of the right?

The same method of interpretation applies. The invention is understood as a product that has the structure or properties, etc. specified by all recitations, and is compared on that basis. If there are clearly unreasonable circumstances, the scope of the right may be limited to the scope of the manufacturing process recited in the claims. [2] [3]

Is this decision still valid?

On 9 October 2026, a case search of the Ministry of Government Legislation returned no decision that overrules this decision. The Supreme Court cited this decision in its decisions of 2015 and 2021. [2] [3] [4] [5]

How DEFINE IP Law Firm handles this

DEFINE IP Law Firm reviews product-by-process claims separately before filing. We check whether the specification states the effect of the manufacturing process on the structure or properties of the product. When a foreign application is adapted for Korea, we check the same point and decide with the applicant whether to include a claim to the manufacturing process as well. For questions about product-by-process claims in Korea, please write to contact@defineip.kr.

Sources

  1. Supreme Court of Korea (대법원), Supreme Court en banc Decision 2011Hu927 Decided January 22, 2015 (2011후927). https://www.law.go.kr/판례/(2011후927) (verified 9 October 2026)
  2. Supreme Court of Korea (대법원), Supreme Court Decision 2013Hu1726 Decided February 12, 2015 (2013후1726). https://www.law.go.kr/판례/(2013후1726) (verified 9 October 2026)
  3. Supreme Court of Korea (대법원), Supreme Court Decision 2020Hu11059 Decided January 28, 2021 (2020후11059). https://www.law.go.kr/판례/(2020후11059) (verified 9 October 2026)
  4. Supreme Court of Korea (대법원), Supreme Court Decision 2020Hu11066 Decided January 28, 2021 (2020후11066). https://www.law.go.kr/판례/(2020후11066) (verified 9 October 2026)
  5. Supreme Court of Korea (대법원), Supreme Court Decision 2019Hu10296 Decided December 30, 2021 (2019후10296). https://www.law.go.kr/판례/(2019후10296) (verified 9 October 2026)
  6. Supreme Court of Korea (대법원), Supreme Court Decision 2004Hu3416 Decided June 29, 2006 (2004후3416). https://www.law.go.kr/판례/(2004후3416) (verified 9 October 2026)
  7. Patent Act (특허법), Act No. 21134, in force from 11 November 2025. Art. 2, subparagraph 3, Art. 29, Art. 42(4) and (6), Art. 97, and Art. 133(1), subparagraph 1. Patent Act (특허법), Act No. 21955, promulgated on 15 September 2026, in force from 16 March 2027. Articles 2, 29, 42, 97 and 133. https://www.law.go.kr/법령/특허법 (verified 9 October 2026)
  8. Patent Act (특허법), Act No. 11848, in force from 1 July 2014. Articles 2, 42 and 97. Patent Act (특허법), Act No. 12753, promulgated on 11 June 2014, in force from 1 January 2015. Articles 2, 42 and 97, Addenda Arts. 1 and 8. Patent Act (특허법), Act No. 16804, promulgated on 10 December 2019, in force from 11 March 2020. Article 2, Addenda. Patent Act (특허법), Act No. 20700, promulgated on 21 January 2025, in force from 22 July 2025. Article 2, Addenda. Version history at https://www.law.go.kr/법령/특허법 (verified 9 October 2026)
  9. Ministry of Intellectual Property (지식재산처), Patent Examination Guidelines (특허·실용신안 심사기준), MOIP Established Rule No. 7, in force from 13 March 2026. Part 2, Chapter 4, 4.(8); Part 3, Chapter 2, 4.1.2 (3); Part 3, Chapter 3, 6.4.4; history of enactment and amendments; Addenda (6 April 2015 and 13 March 2026). https://www.law.go.kr/행정규칙/특허·실용신안심사기준 (verified 9 October 2026)